Terns Pharmaceuticals, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
TERN Nasdaq 2830 www.ternspharma.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Terns Pharmaceuticals, Inc.

This Weight Loss Stock Could Skyrocket by 462%, According to Wall Street - Mar 9th, 2025 2:03 pm
Terns Pharmaceuticals Reports Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(C)(4) - Feb 26th, 2025 9:05 pm
Terns Pharmaceuticals Provides Program Updates and Announces Participation at TD Cowen 45th Annual Healthcare Conference - Feb 25th, 2025 1:05 pm
Its CEO died. The company scrapped a promising program. Now, for their 2nd act. - Feb 25th, 2025 8:00 am
Terns Pharmaceuticals Appoints Andrew Gengos as Chief Financial Officer - Feb 24th, 2025 9:05 pm
Terns Pharmaceuticals Appoints Robert Azelby to Board of Directors - Feb 20th, 2025 9:05 pm
Terns Pharmaceuticals to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference - Feb 5th, 2025 9:05 pm
Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4) - Feb 3rd, 2025 9:05 pm
Terns Pharmaceuticals to Present at 43rd Annual J.P. Morgan Healthcare Conference - Jan 8th, 2025 9:05 pm
Is Terns Pharmaceuticals, Inc. (TERN) the Best Weight Loss Stock to Buy Now According to Hedge Funds? - Dec 16th, 2024 6:10 pm
Terns Pharmaceuticals CEO & Director Acquires 423% More Stock - Dec 11th, 2024 10:30 am
Terns Pharmaceuticals Announces Positive Early Data from Phase 1 CARDINAL Trial of TERN-701 for Chronic Myeloid Leukemia - Dec 3rd, 2024 12:00 pm
Terns Pharmaceuticals Appoints Heather Turner, J.D., to Board of Directors - Nov 18th, 2024 9:05 pm
We Think Terns Pharmaceuticals (NASDAQ:TERN) Can Afford To Drive Business Growth - Nov 14th, 2024 10:17 am
Terns Pharmaceuticals Reports Third Quarter 2024 Financial Results and Corporate Updates - Nov 12th, 2024 9:05 pm
Terns Pharmaceuticals to Participate in Upcoming November Investor Conferences - Nov 6th, 2024 9:05 pm
Insiders Snap Up These 2 ‘Strong Buy’ Stocks - Sep 24th, 2024 7:22 am
This Small-Cap Stock Has a Promising GLP-1 Drug That Could Rival Novo Nordisk's and Eli Lilly's Weight Loss Treatments - Sep 18th, 2024 2:07 pm
OrbiMed Advisors LLC Increases Stake in Terns Pharmaceuticals Inc - Sep 17th, 2024 5:30 am
With 55% ownership, Terns Pharmaceuticals, Inc. (NASDAQ:TERN) boasts of strong institutional backing - Sep 16th, 2024 2:14 pm